✦ LIBER ✦

Phase I trial of docetaxel, carboplatin, and gemcitabine as first-line therapy for patients with high-risk epithelial tumors of müllerian origin

✍ Scribed by Anna Berkenblit; Nadine Tung; Young Kim; Heidi Feyler; Jonathan Niloff; Karen Van Den Berghe; Stephen A Cannistra

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel and g

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

Phase I/II Trial of Docetaxel and Carbop

✍ Kensuke Kataoka; Ryujiro Suzuki; Hiroyuki Taniguchi; Yasunobu Noda; Joe Shindoh; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 82 KB

Phase I Trial of Carboplatin, Paclitaxel

✍ Nadine Tung; Ross Berkowitz; Ursula Matulonis; Marc Quartulli; Michael Seiden; Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Results of a phase II multicenter trial

✍ Neubauer, Marcus A.; Garfield, David H.; Kuerfler, Paul R.; Raju, Robert N.; Lin 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Gemcitabine and oxaliplatin followed by

✍ C.B. Steer; K. Chrystal; K.A. Cheong; E. Galani; G.M. Marx; A.H. Strickland; D. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 146 KB

A phase II trial of docetaxel and erloti

✍ Mitchell Gross; Celestia Higano; Allan Pantuck; Olga Castellanos; Erica Green; K 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 278 KB